Key statistics
As of last trade, Collegium Pharmaceutical Inc (354:BER) traded at 28.80, 24.14% above the 52 week low of 23.20 set on Nov 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 28.80 |
---|---|
High | 28.80 |
Low | 28.80 |
Bid | 29.00 |
Offer | 29.40 |
Previous close | 28.20 |
Average volume | 7.44 |
---|---|
Shares outstanding | 32.25m |
Free float | 31.72m |
P/E (TTM) | 15.21 |
Market cap | 980.73m USD |
EPS (TTM) | 2.00 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 07:13 GMT.
More ▼
Announcements
- Collegium to Participate in Upcoming Investor Conferences
- Collegium Reports Record Third Quarter 2024 Financial Results
- Collegium Appoints Vikram Karnani as Chief Executive Officer
- Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024
- Collegium Completes Acquisition of Ironshore Therapeutics
- Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference
- Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024
- Collegium Reports Second Quarter 2024 Financial Results
- Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology
- Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024
More ▼